Business Context and Reporting Period
This Form 6-K filing contains the minutes of the Extraordinary General Shareholders' Meeting of AMBEV S.A. held on January 2, 2014. The meeting addressed corporate restructuring through mergers, amendments to the Company's Bylaws, and the election of a new Board of Directors. The filing does not contain financial performance data for a specific reporting period (e.g., Q4 2013 or FY 2013) but focuses on corporate governance and structural changes.
Key Financial Metrics and Capital Structure
The filing does not provide revenue, profit, cash flow, or margin data. However, it details specific capital structure changes resulting from approved mergers:
- Capital Stock: The total capital stock was amended to R$57,000,946,244.65.
- Share Count: The capital is divided into 15,664,342,206 nominative common shares without par value.
- Capital Increase: As a result of Merger II (merger with Ambev Brasil), 62,596 new common shares were issued at an aggregate price of R$156,566.05 to minority shareholders of Ambev Brasil.
- Treasury Stock: Following Merger I, 48,440 Company shares previously held by Ambev Brasil were transferred to the Company's treasury.
Material Changes
The primary material changes approved by shareholders include:
- Merger I: Approval of the merger of Companhia de Bebidas das Américas - Ambev (a wholly-owned subsidiary) into Ambev S.A. This transaction did not result in a change to net equity or capital stock as the subsidiary was already fully consolidated.
- Merger II: Approval of the merger of Ambev Brasil Bebidas S.A. into Ambev S.A. This resulted in the issuance of new shares to minority shareholders of Ambev Brasil and the cancellation of shares held by the Company.
- Bylaws Amendment: The Company's purpose was expanded to include printing services and the trading of byproducts for animal feeding. The capital stock article was updated to reflect the new share count and total capital value.
- Board Composition: A new slate of 11 effective Board members and 1 alternate was elected, including two independent directors.
Outlook, Risks, and Contingencies
The filing outlines specific contingencies and rights related to the mergers:
- Appraisal Rights: Shareholders of Ambev Brasil who did not vote in favor of Merger II have the right to exercise appraisal rights. They may request reimbursement based on either the book value (R$2.861419 per share as of Dec 31, 2012) or the market value calculated in the Net Equity Valuation Report II (R$1.835073 per share).
- Fractional Shares: Shareholders receiving fractional entitlements from Merger II have 30 days to form indivisible shares. Unresolved fractional shares will be paid in cash based on book value.
- Valuation Reports: The Company retained Apsis Consultoria Empresarial Ltda. to prepare valuation reports for both mergers to ensure compliance with Brazilian Law No. 6,404/76.
Investor Verification Checklist
- Verify the final share count and capital stock value (R$57.0 billion) in subsequent filings to confirm the execution of the capital increase.
- Monitor the exercise of appraisal rights by Ambev Brasil minority shareholders and the associated cash outflow for reimbursements.
- Review the composition of the newly elected Board of Directors to confirm the presence of the required independent members.
- Confirm the legal dissolution of Companhia de Bebidas das Américas and Ambev Brasil Bebidas S.A. as per the merger resolutions.
- Check for the publication of the "Notice to Shareholders" regarding the payment date for appraisal rights and fractional share cash payments.